Dobutamine (Compound)

Synonyms:dobutamine, 34368-04-2, DL-dobutamine, racemic-Dobutamine, Dobutamina, Racemic dobutamine, Dobutaminum, rac-dobutamine, Compound 81929, 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol, CHEMBL926, 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol, LY 81929, (+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol, COMPOUND-81929, CHEBI:4670, DTXSID3022958, Dobutaminum [INN-Latin], Dobutamina [INN-Spanish], Dobutamine [USAN], NCGC00015321-04, 3S12J47372, 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine, 4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol, DTXCID702958, (+/-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol, CAS-34368-04-2, (+/-)-dobutamine, DOBUTAMINEHYDROCHLORIDE, 4-(2-(4-(4-hydroxyphenyl)butan-2-ylamino)ethyl)benzene-1,2-diol, Dobutamine [USAN:USP:INN:BAN], UNII-3S12J47372, (-)-Dobutamine, 1,2-BENZENEDIOL, 4-(2-((3-(4-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)-, DOBUTAMINE [MI], DOBUTAMINE [INN], Dobutamine (USAN/INN), Prestwick0_000352, Prestwick1_000352, Prestwick2_000352, Prestwick3_000352, DOBUTAMINE [VANDF], 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-, DOBUTAMINE [WHO-DD], Lopac0_000365, SCHEMBL21237, BSPBio_000443, GTPL535, cid_36811, SPBio_002364, BPBio1_000489, DOBUTAMINE [USP IMPURITY], HMS2089K05, AMY40802, Tox21_110126, BBL033719, BDBM50325274, HY-15746A, STL373008, 4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)benzene-1,2-diol, AKOS025248013, Tox21_110126_1, CCG-204460, DB00841, SDCCGSBI-0050353.P002, NCGC00015321-03, NCGC00015321-05, NCGC00015321-06, NCGC00015321-07, NCGC00015321-08, NCGC00015321-09, NCGC00015321-11, NCGC00015321-18, NCGC00024629-02, NCGC00024629-03, VS-12236, CS-0013581, FT-0625556, C06967, D03879, EN300-18539446, L001157, Q422782, SR-01000075265-9, BRD-A78322124-003-03-3, 4-[2-[3-(4-Hydroxyphenyl)-1-methylpropylamino]ethyl]pyrocatechol, 4-(2-([3-(4-Hydroxyphenyl)-1-methylpropyl]amino)ethyl)-1,2-benzenediol #, 4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol, (.+/-.)-4-[2-[[3-(p-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol, 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, (.+/-.)-, 4-(2-((3-(4-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)-1,2-BENZENEDIOL, 4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol(Dobutamine), 1,2-BENZENEDIOL, 4-(2-((3-(4-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)-, (+/-)-
Pubchem:PUBCHEM:36811
Id:2ed71064-4efd-5de5-87bd-a70aae4e7dd4
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Dobutamine's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Dobutamine.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Dobutamine.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.